S Forbes1, S D Taylor-Robinson, N Patel, P Allan, B R Walker, D G Johnston. 1. Endocrinology Unit, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. Shareen.Forbes@ed.ac.uk
Abstract
AIMS/HYPOTHESIS: Non-alcoholic fatty liver disease (NAFLD) is common in type 2 diabetes but it is unknown whether NAFLD is prevalent in European women at risk of type 2 diabetes. We studied the prevalence of, and risk factors for, NAFLD in European women with previous gestational diabetes (GDM) at high risk of type 2 diabetes. METHODS: A total of 110 women with previous GDM and 113 without previous GDM, with non-diabetic glucose tolerance were recruited retrospectively from antenatal databases. Participants underwent liver ultrasound scan examination, anthropometry and blood sampling for liver function tests and to determine levels of fasting lipids, NEFA and insulin and glucose concentrations in order to derive insulin sensitivity and insulin secretion indices (HOMA%S and HOMA%B, respectively). RESULTS: There was no significant difference in BMI in women with previous GDM compared with those without previous GDM (28.9 ± 0.6 vs. 27.9 ± 0.6 kg/m(2), respectively; p = 0.12). Women with previous GDM had higher fasting and 2 h glucose concentrations following a 75 g OGTT ([mean ± SEM] fasting glucose 5.3 ± 0.1 vs. 5.1 ± 0.1 mmol/l, p = 0.02; 2 h glucose 6.8 ± 0.2 vs. 5.8 ± 0.3 mmol/l, p = 0.02), dyslipidaemia (LDL-cholesterol 3.3 ± 0.1 vs. 2.8 ± 0.1 mmol/l; HDL-cholesterol [median {interquartile range}] 1.3 [1.2-1.6] vs. 1.8 [1.5-1.9] mmol/l; triacylglycerol 1.3 [0.9-1.6] vs. 1.0 [0.7-1.7] mmol/l, all p ≤ 0.03), higher insulin secretion and lower insulin sensitivity. NAFLD prevalence was greater in women with previous GDM compared with those without previous GDM: 38% (95% CI 28-47%) vs. 17% (95% CI 10-24%), p = 0.001. In multiple logistic regression analysis, lower insulin sensitivity and raised serum alanine transaminase concentrations were associated with NAFLD. CONCLUSIONS/ INTERPRETATION: NAFLD is prevalent in European women with previous GDM. Impaired insulin sensitivity and increased liver transaminase activity are closely associated with NAFLD in these women.
AIMS/HYPOTHESIS: Non-alcoholic fatty liver disease (NAFLD) is common in type 2 diabetes but it is unknown whether NAFLD is prevalent in European women at risk of type 2 diabetes. We studied the prevalence of, and risk factors for, NAFLD in European women with previous gestational diabetes (GDM) at high risk of type 2 diabetes. METHODS: A total of 110 women with previous GDM and 113 without previous GDM, with non-diabetic glucose tolerance were recruited retrospectively from antenatal databases. Participants underwent liver ultrasound scan examination, anthropometry and blood sampling for liver function tests and to determine levels of fasting lipids, NEFA and insulin and glucose concentrations in order to derive insulin sensitivity and insulin secretion indices (HOMA%S and HOMA%B, respectively). RESULTS: There was no significant difference in BMI in women with previous GDM compared with those without previous GDM (28.9 ± 0.6 vs. 27.9 ± 0.6 kg/m(2), respectively; p = 0.12). Women with previous GDM had higher fasting and 2 h glucose concentrations following a 75 g OGTT ([mean ± SEM] fasting glucose 5.3 ± 0.1 vs. 5.1 ± 0.1 mmol/l, p = 0.02; 2 h glucose 6.8 ± 0.2 vs. 5.8 ± 0.3 mmol/l, p = 0.02), dyslipidaemia (LDL-cholesterol 3.3 ± 0.1 vs. 2.8 ± 0.1 mmol/l; HDL-cholesterol [median {interquartile range}] 1.3 [1.2-1.6] vs. 1.8 [1.5-1.9] mmol/l; triacylglycerol 1.3 [0.9-1.6] vs. 1.0 [0.7-1.7] mmol/l, all p ≤ 0.03), higher insulin secretion and lower insulin sensitivity. NAFLD prevalence was greater in women with previous GDM compared with those without previous GDM: 38% (95% CI 28-47%) vs. 17% (95% CI 10-24%), p = 0.001. In multiple logistic regression analysis, lower insulin sensitivity and raised serum alanine transaminase concentrations were associated with NAFLD. CONCLUSIONS/ INTERPRETATION: NAFLD is prevalent in European women with previous GDM. Impaired insulin sensitivity and increased liver transaminase activity are closely associated with NAFLD in these women.
Authors: Shivakumar Chitturi; Shehan Abeygunasekera; Geoffrey C Farrell; Jane Holmes-Walker; Jason M Hui; Caroline Fung; Rooshdiya Karim; Rita Lin; Dev Samarasinghe; Christopher Liddle; Martin Weltman; Jacob George Journal: Hepatology Date: 2002-02 Impact factor: 17.425
Authors: Shareen Forbes; Stephen Robinson; Jason Dungu; Victor Anyaoku; Peter Bannister; David Forster; Sujata Dissanayake; Mark I McCarthy; Ian A MacDonald; Soundararajan Venkatesan; Desmond G Johnston Journal: Eur J Endocrinol Date: 2006-09 Impact factor: 6.664
Authors: L O Ohlson; B Larsson; P Björntorp; H Eriksson; K Svärdsudd; L Welin; G Tibblin; L Wilhelmsen Journal: Diabetologia Date: 1988-11 Impact factor: 10.122
Authors: Abigail Fraser; Ross Harris; Naveed Sattar; Shah Ebrahim; George Davey Smith; Debbie A Lawlor Journal: Diabetes Care Date: 2009-01-08 Impact factor: 17.152
Authors: Seung Mi Lee; Soo Heon Kwak; Ja Nam Koo; Ig Hwan Oh; Jeong Eun Kwon; Byoung Jae Kim; Sun Min Kim; Sang Youn Kim; Gyoung Min Kim; Sae Kyung Joo; Bo Kyung Koo; Sue Shin; Chanthalakeo Vixay; Errol R Norwitz; Chan-Wook Park; Jong Kwan Jun; Won Kim; Joong Shin Park Journal: Diabetologia Date: 2018-11-23 Impact factor: 10.122
Authors: Sarah R Donnelly; Stefanie N Hinkle; Shristi Rawal; Louise G Grunnet; Jorge E Chavarro; Allan Vaag; Jing Wu; Peter Damm; James L Mills; Mengying Li; Anne A Bjerregaard; Anne Cathrine B Thuesen; Robert E Gore-Langton; Ellen C Francis; Sylvia H Ley; Frank B Hu; Michael Y Tsai; Sjurdur F Olsen; Cuilin Zhang Journal: J Diabetes Date: 2019-06-12 Impact factor: 4.006
Authors: Leanne R De Souza; Howard Berger; Ravi Retnakaran; Paraskevi A Vlachou; Jonathon L Maguire; Avery B Nathens; Philip W Connelly; Joel G Ray Journal: Am J Gastroenterol Date: 2016-03-15 Impact factor: 10.864
Authors: S Forbes; I F Godsland; S D Taylor-Robinson; J D Bell; E L Thomas; N Patel; G Hamilton; K H Parker; I Marshall; C D Gray; D Bedford; M Caslake; B R Walker; D G Johnston Journal: Diabetologia Date: 2013-06-13 Impact factor: 10.122
Authors: Latife Bozkurt; Christian S Göbl; Andrea Tura; Marek Chmelik; Thomas Prikoszovich; Lana Kosi; Oswald Wagner; Michael Roden; Giovanni Pacini; Amalia Gastaldelli; Alexandra Kautzky-Willer Journal: PLoS One Date: 2012-02-29 Impact factor: 3.240
Authors: Barbara J Meyer; Frances M Stewart; Elizabeth A Brown; Josephine Cooney; Solveig Nilsson; Gunilla Olivecrona; Jane E Ramsay; Bruce A Griffin; Muriel J Caslake; Dilys J Freeman Journal: J Clin Endocrinol Metab Date: 2013-01-21 Impact factor: 5.958
Authors: Veeral H Ajmera; Erica P Gunderson; Lisa B VanWagner; Cora E Lewis; John J Carr; Norah A Terrault Journal: Am J Gastroenterol Date: 2016-03-22 Impact factor: 12.045